WNYUZ
No Result
View All Result
  • Home
  • Politics
  • Opinion
  • Business
  • World
  • Health
  • Entertainment
  • Tech
  • Home
  • Politics
  • Opinion
  • Business
  • World
  • Health
  • Entertainment
  • Tech
No Result
View All Result
WNYUZ
No Result
View All Result
Home News

FDA approves Moderna’s new lower-dose COVID-19 vaccine

May 31, 2025
in News
Yahoo news home
491
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second option.

The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It’s made in a way that allows for a lower dose — a fifth of the dose of its current COVID-19 vaccine, Spikevax — by refining its immune target.

The approval “adds an important new tool to help protect people at high risk of severe disease from COVID-19,” Stephane Bancel, Moderna’s CEO, said in a statement Saturday.

The Food and Drug Administration approved the new vaccine for use in all adults 65 and older, and for people age 12 to 64 who have a least one health condition that puts them at increased risk from the coronavirus.

That’s the same limit that the FDA set in licensing another COVID-19 vaccine option from competitor Novavax.

Those restrictions are a departure from how the U.S. has handled COVID-19 vaccines until now, reflecting skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. and other Trump officials.

Moderna’s existing vaccine doesn’t face those limits and has long been used for anyone ages 6 months and older. The company said it expected to offer both options this fall.

The FDA’s approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna’s existing vaccine. It found the new vaccine was safe and was at least as effective — and more by some measures — than the original shot, the company said.

The news came just days after the Trump administration canceled funding for Moderna to develop a vaccine against potential pandemic flu viruses, including the H5N1 bird flu, despite promising early study results.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

The post FDA approves Moderna’s new lower-dose COVID-19 vaccine appeared first on Associated Press.

Tags: Associated PressFood and Drug AdministrationHealth Secretary Robert F. Kennedy Jr.ModernaStephane BancelvaccineYahooYahoo News
Share196Tweet123Share
Yahoo news home
News

Trump’s big tax bill moves ahead to potential changes in the Senate

June 2, 2025

WASHINGTON – House Republicans have done their job, narrowly passing President Donald Trump's sweeping tax and policy bill. Next up: ...

Read more
News

Newark Airport to open its shuttered runway Monday, 13 days ahead of schedule

June 2, 2025
News

Suspect threw Molotov cocktails in terror attack at rally for Israeli hostages

June 2, 2025
News

Taylor Swift got what she wanted. So what do ‘Taylor’s Versions’ mean now?

June 2, 2025
News

Exercise may benefit colon cancer patients as much as some drugs

June 2, 2025
Yahoo news home

What we know about the suspect and victims in the Boulder, Colorado, attack

June 2, 2025
Trump tariffs face threat at Supreme Court — over rulings that blocked Biden

Trump tariffs face threat at Supreme Court — over rulings that blocked Biden

June 1, 2025
Yahoo news home

Salmonella outbreak in cucumbers expands to 18 states; 45 sickened

June 1, 2025

© 2025 WNyuz.com

No Result
View All Result
  • Home
  • Politics
  • Opinion
  • Business
  • World
  • Health
  • Entertainment
  • Tech

© 2025 WNyuz.com